Completed

Phase 3
Age: 13Years +
FEMALE
ID00001073

A Randomized Phase III Trial of Oral Isotretinoin Versus Observation for Low-Grade Squamous Intraepithelial Lesions in HIV-Infected Women

Led by National Institute of Allergy and Infectious Diseases (NIAID) · Updated on 2021-11-04

150

Participants Needed

40

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of this study is to see if it is safe and effective to give isotretinoin to HIV-infected women with cervical tumors to prevent these tumors from becoming cancerous. Cervical tumors are found in both HIV-infected and HIV-negative women. However, HIV-infected women are at a greater risk, and often their tumors become cancerous more quickly than those in HIV-negative women. Isotretinoin may be able to prevent this from happening. However, since these tumors tend to disappear over time, many doctors are hesitant to give their patients isotretinoin since this drug causes birth defects. This study looks at whether it is better to treat cervical tumors in HIV-infected women or to wait and see if they will disappear by themselves.

CONDITIONS

Official Title

Safety and Effectiveness of Giving Isotretinoin to HIV-Infected Women to Treat Cervical Tumors

Who Can Participate

Age: 13Years +
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

Inclusion Criteria

You may be eligible for this study if you:

  • Are an HIV-positive female.
  • Are at least 13 years old. (Need consent of parent or guardian if under 18.)
  • Have cervical tumors, as determined by a biopsy performed by a doctor.
  • Agree to use both condoms and the pill during the study.

Exclusion Criteria

You will not be eligible for this study if you:

  • Have received certain cancer therapies (such as chemotherapy) within the past 3 or 4 months.
  • Have had a hysterectomy (uterus removed) within the past 4 months.
  • Are taking tetracycline or Vitamin A.
  • Have taken certain medications. (Approved anti-HIV drugs and medications to prevent AIDS-related opportunistic infections are okay.)
  • Are pregnant.
Not Eligible

You will not qualify if you...

History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety

Trial Site Locations

Total: 40 locations

1

Alabama Therapeutics CRS

Birmingham, Alabama, United States, 35294

Status Unknown

2

USC CRS

Los Angeles, California, United States, 90033

Status Unknown

3

UCLA CARE Center CRS

Los Angeles, California, United States, 90095

Status Unknown

4

Usc La Nichd Crs

Los Angeles, California, United States

Status Unknown

5

Ucsd, Avrc Crs

San Diego, California, United States, 92103

Status Unknown

6

Ucsf Aids Crs

San Francisco, California, United States

Status Unknown

7

Santa Clara Valley Med. Ctr.

San Jose, California, United States, 95128

Status Unknown

8

San Mateo County AIDS Program

San Mateo, California, United States, 94305

Status Unknown

9

Howard University Hosp., Div. of Infectious Diseases, ACTU

Washington D.C., District of Columbia, United States, 20059

Status Unknown

10

South Florida CDC Ft Lauderdale NICHD CRS

Fort Lauderdale, Florida, United States

Status Unknown

11

Univ. of Florida Jacksonville NICHD CRS

Jacksonville, Florida, United States

Status Unknown

12

Univ. of Miami AIDS CRS

Miami, Florida, United States, 33136

Status Unknown

13

Univ. of Hawaii at Manoa, Leahi Hosp.

Honolulu, Hawaii, United States, 96816

Status Unknown

14

Northwestern University CRS

Chicago, Illinois, United States, 60611

Status Unknown

15

Rush Univ. Med. Ctr. ACTG CRS

Chicago, Illinois, United States, 60612

Status Unknown

16

Univ. of Chicago - Dept. of Peds., Div. of Infectious Disease

Chicago, Illinois, United States

Status Unknown

17

Indiana Univ. School of Medicine, Infectious Disease Research Clinic

Indianapolis, Indiana, United States, 46202

Status Unknown

18

Tulane Med. Ctr. - Charity Hosp. of New Orleans, ACTU

New Orleans, Louisiana, United States, 70112

Status Unknown

19

Tulane/LSU Maternal/Child CRS

New Orleans, Louisiana, United States, 70112

Status Unknown

20

Johns Hopkins Adult AIDS CRS

Baltimore, Maryland, United States, 21287

Status Unknown

21

Bmc Actg Crs

Boston, Massachusetts, United States, 02118

Status Unknown

22

St. Louis ConnectCare, Infectious Diseases Clinic

St Louis, Missouri, United States, 63112

Status Unknown

23

Washington U CRS

St Louis, Missouri, United States

Status Unknown

24

Univ. of Nebraska Med. Ctr., Durham Outpatient Ctr.

Omaha, Nebraska, United States, 68198

Status Unknown

25

NJ Med. School CRS

Newark, New Jersey, United States

Status Unknown

26

SUNY - Buffalo, Erie County Medical Ctr.

Buffalo, New York, United States, 14215

Status Unknown

27

Beth Israel Med. Ctr. (Mt. Sinai)

New York, New York, United States, 10003

Status Unknown

28

NY Univ. HIV/AIDS CRS

New York, New York, United States, 10016

Status Unknown

29

Memorial Sloan-Kettering Cancer Ctr.

New York, New York, United States, 10021

Status Unknown

30

Univ. of Rochester ACTG CRS

Rochester, New York, United States, 14642

Status Unknown

31

SUNY Upstate Med. Univ., Dept. of Peds.

Syracuse, New York, United States

Status Unknown

32

Unc Aids Crs

Chapel Hill, North Carolina, United States, 275997215

Status Unknown

33

Duke Univ. Med. Ctr. Adult CRS

Durham, North Carolina, United States, 27710

Status Unknown

34

The Ohio State Univ. AIDS CRS

Columbus, Ohio, United States

Status Unknown

35

Hosp. of the Univ. of Pennsylvania CRS

Philadelphia, Pennsylvania, United States, 19104

Status Unknown

36

University of Washington AIDS CRS

Seattle, Washington, United States, 98104

Status Unknown

37

UW School of Medicine - CHRMC

Seattle, Washington, United States

Status Unknown

38

Puerto Rico-AIDS CRS

San Juan, Puerto Rico

Status Unknown

39

San Juan City Hosp. PR NICHD CRS

San Juan, Puerto Rico

Status Unknown

40

Mbeya Med. Research Program, Mbeya Referral Hosp. CRS

Mbeya, Tanzania

Status Unknown

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

TREATMENT

Number of Arms

0

Similar Trials

ACTION HIV: A Global Record of Anal Squamous Cell Carcinoma ...

Anal Squamous Cell Carcinoma

Actively Recruiting

1 location

Long-term Follow-up Study of HIV-infected Individuals in HIV...

HIV Infections

Actively Recruiting

1 location

Evaluation of Oral VH4524184 with Emtricitabine and Tenofovi...

HIV Infections

Actively Recruiting

113 locations

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial